Efficacy of long-acting, injectable versus oral naltrexone for preventing admissions for alcohol use disorder
{{output}}
Introduction: Approximately 17 million Americans and 300 000 veterans have an alcohol use disorder (AUD). Both oral naltrexone (NTX) and long-acting, injectable naltrexone (LAI NTX) are FDA-approved to treat AUD. LAI NTX is often... ...
